The External Advisory Board (EAB) supports the strategic development of the Institute of Applied Biosciences, enhancing the Institute’s continuous effort to achieve both scientific excellence and industry applicability. The EAB was enacted on September, 2022. It consists of 5 members, highly recognized and reputable in their respective fields. For the 2020-2024 mission, the External Advisory Board consists of the following members:
Constantinos Constantinidis
Owner and CEO, PELOPAC, Greece
Marie-Christine Jaulent
Research Director, National Institute of Health and Medical Research (INSERM), France
John Weinman
Professor of Psychology – School of Cancer & Pharmaceutical Sciences & Emeritus Professor at the Institute of Psychiatry, Psychology & Neuroscience in King’s College London. Co-Director of the KCL/KHP Centre for Adherence Research & Education, UK
Phillip N. Tsichlis
Chair, Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, US
Richard Rosenquist Brandell
Professor of Clinical Genetics at the Department of Molecular Medicine and Surgery, Karolinska Institutet & Senior Physician in Clinical Genetics at Karolinska University Hospital, Sweden
